Panion & BF Biotech Inc. (1760) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Panion & BF Biotech Inc. (1760:TWSE), powered by AI.

Current Price
$59.90
Sector
Healthcare
What is the Panion & BF Biotech Inc. stock price forecast?

Panion & BF Biotech Inc. is currently trading at $59.90. View real-time AI analysis on Alpha Lenz.

What is Panion & BF Biotech Inc. insider trading activity?

View the latest insider trading data for Panion & BF Biotech Inc. on Alpha Lenz.

What is Panion & BF Biotech Inc.'s P/E ratio?

View Panion & BF Biotech Inc.'s valuation metrics on Alpha Lenz.

Panion & BF Biotech Inc.

TWSE · 1760
NT$59.90+0.30(+0.50%)
Ask about Panion & BF Biotech Inc.'s future dividend policy...
Alpha Chat Insight

Panion & BF Biotech Inc.'s ROE is 9.8%. Explore profitability and growth together.

Ask for details

Company Overview

Panion & BF Biotech Inc. is a specialized company in the biotechnology sector. Its primary purpose is to develop, produce, and market pharmaceutical products and biotechnology-related health solutions. The company's expertise lies in the fields of biologics and pharmaceuticals, targeting critical areas such as oncology, vaccines, and rare diseases. Biotech firms like Panion & BF Biotech play significant roles in advancing medical science and improving patient health outcomes. By focusing on innovative therapeutic options and leveraging cutting-edge biotechnology techniques, they contribute to the development of new medicines and treatments that address unmet medical needs. In the financial markets, biotechnology companies are pivotal for their potential impact on healthcare innovation, often drawing interest from investors focused on long-term growth in the health sciences sector. With an emphasis on research and development, Panion & BF Biotech aids in expanding the potential solutions available for complex health challenges globally.

SectorHealthcare
IndustryBiotechnology
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$2.06BRevenue
0.00Shares Out
0Employees

Margins

54.13%Gross
21.69%EBITDA
14.96%Operating
14.25%Pre-Tax
9.22%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-4.89%Rev 3Yr
5.64%Rev 5Yr
-9.32%Op Inc 3Yr
19.47%Op Inc 5Yr
1.41%Net Inc 3Yr
46.79%Net Inc 5Yr

Returns

5.91%ROA
9.81%ROE
9.58%ROIC

Financial Health

NT$460.32MCash & Cash Equivalents
NT$811.71MNet Debt
65.08%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Panion & BF Biotech Inc. (ticker: 1760) is a company listed on TWSE in the Healthcare sector (Biotechnology).

The current price is 59.9 with a P/E ratio of -x and P/B of -x.

ROE is 9.81% and operating margin is 14.96%. Annual revenue is $2.1B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Panion & BF Biotech Inc. (1760) Stock Forecast 2026 $59.90 — Price, Financials & Analyst Targets | Alpha Lenz